Angiogenesis inhibitor

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 11, 536 551, 536123, A61K 31715, C02H 100

Patent

active

049754220

ABSTRACT:
The present invention discloses an angiogenesis inhibitor containing as an active ingredient protein-polysaccharides produced by extraction of mycelia or fruit bodies obtained from culture of a Basidiomycete belonging to a genus Coriolus.
The protein-polysaccharide contains about 18 to about 38% by weight of protein, being free from protein-polysaccharides having molecular weight of less than 5,000.
More in detail, said protein-polysaccharides of the present invention contain 3 to 6% of nitrogen, a polysaccharide portion thereof, as the main fraction, is composed of .beta.-D-glucan and this glucan portion has branched structures containing 1.fwdarw.3, 1.fwdarw.4 and 1.fwdarw.6 bonds, wherein the protein-component amino acids are mostly acidic amino acids of aspartic acid and glutamic acid, and neutral amino acids of valine and leucine, while the basic amino acids of lysine and alginine are small in content, and the protein-polysaccharide is soluble in water but hardly soluble in methanol, pyridine, chloroform, benzene and hexane and starts to be gradually decomposed at about 120.degree. C.

REFERENCES:
patent: 4182753 (1980-01-01), Saltarelli
patent: 4202885 (1980-05-01), Asano et al.
patent: 4202966 (1980-05-01), Misaki et al.
patent: 4202969 (1980-05-01), Ueno et al.
patent: 4229570 (1980-10-01), Ueno et al.
patent: 4614733 (1986-09-01), Yoshikumi et al.
Patent Abstracts of Japan, vol. 10, No. 287 (C-375) [2343], Sep. 30, 1986.
Dialog Information Services, file 159, Cancerlit 63-89, Accesion No. 0108234, Kubota, "Experimental Chemotherapy of Carcinomas of the . . . ".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Angiogenesis inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Angiogenesis inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiogenesis inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-883472

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.